ArticleJournal of neuro-oncology2010

Osteopontin expression is a valuable marker for prediction of short-term recurrence in WHO grade I benign meningiomas.

Kuan-Yin Tseng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.